BE623473A - - Google Patents
Info
- Publication number
- BE623473A BE623473A BE623473DA BE623473A BE 623473 A BE623473 A BE 623473A BE 623473D A BE623473D A BE 623473DA BE 623473 A BE623473 A BE 623473A
- Authority
- BE
- Belgium
- Prior art keywords
- lysozyme
- vitamin
- pharmaceutical form
- cases
- compositions consisting
- Prior art date
Links
- 102000016943 Muramidase Human genes 0.000 claims description 18
- 108010014251 Muramidase Proteins 0.000 claims description 18
- 108010062010 N-Acetylmuramoyl-L-alanine Amidase Proteins 0.000 claims description 18
- 229960000274 lysozyme Drugs 0.000 claims description 18
- 235000010335 lysozyme Nutrition 0.000 claims description 18
- 239000004325 lysozyme Substances 0.000 claims description 18
- 239000000203 mixture Substances 0.000 claims description 7
- 238000011282 treatment Methods 0.000 claims description 7
- 230000003628 erosive effect Effects 0.000 claims description 6
- 208000002399 aphthous stomatitis Diseases 0.000 claims description 4
- 239000007937 lozenge Substances 0.000 claims description 4
- 239000006190 sub-lingual tablet Substances 0.000 claims description 4
- 235000015218 chewing gum Nutrition 0.000 claims description 2
- 229940034610 toothpaste Drugs 0.000 claims description 2
- 239000000606 toothpaste Substances 0.000 claims description 2
- RBCOYOYDYNXAFA-UHFFFAOYSA-L (5-hydroxy-4,6-dimethylpyridin-3-yl)methyl phosphate Chemical compound CC1=NC=C(COP([O-])([O-])=O)C(C)=C1O RBCOYOYDYNXAFA-UHFFFAOYSA-L 0.000 claims 4
- 239000011720 vitamin B Substances 0.000 description 8
- 229930003270 Vitamin B Natural products 0.000 description 7
- 235000019156 vitamin B Nutrition 0.000 description 7
- 208000025865 Ulcer Diseases 0.000 description 6
- 230000000694 effects Effects 0.000 description 6
- 230000036269 ulceration Effects 0.000 description 5
- 206010039897 Sedation Diseases 0.000 description 3
- 230000035876 healing Effects 0.000 description 3
- 230000002757 inflammatory effect Effects 0.000 description 3
- 230000036280 sedation Effects 0.000 description 3
- 238000002560 therapeutic procedure Methods 0.000 description 3
- 239000003242 anti bacterial agent Substances 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 210000000214 mouth Anatomy 0.000 description 2
- LXNHXLLTXMVWPM-UHFFFAOYSA-N pyridoxine Chemical compound CC1=NC=C(CO)C(CO)=C1O LXNHXLLTXMVWPM-UHFFFAOYSA-N 0.000 description 2
- 102000006395 Globulins Human genes 0.000 description 1
- 108010044091 Globulins Proteins 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 101710093543 Probable non-specific lipid-transfer protein Proteins 0.000 description 1
- 206010042566 Superinfection Diseases 0.000 description 1
- 230000001464 adherent effect Effects 0.000 description 1
- 239000000443 aerosol Substances 0.000 description 1
- 230000002421 anti-septic effect Effects 0.000 description 1
- 230000002155 anti-virotic effect Effects 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 229940064004 antiseptic throat preparations Drugs 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 208000020670 canker sore Diseases 0.000 description 1
- 235000012730 carminic acid Nutrition 0.000 description 1
- 239000003246 corticosteroid Substances 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 230000008034 disappearance Effects 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000000890 drug combination Substances 0.000 description 1
- 210000002615 epidermis Anatomy 0.000 description 1
- 239000003102 growth factor Substances 0.000 description 1
- 238000005470 impregnation Methods 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 210000004877 mucosa Anatomy 0.000 description 1
- 210000001989 nasopharynx Anatomy 0.000 description 1
- 239000002547 new drug Substances 0.000 description 1
- 230000001766 physiological effect Effects 0.000 description 1
- 230000000750 progressive effect Effects 0.000 description 1
- 238000011321 prophylaxis Methods 0.000 description 1
- 235000008160 pyridoxine Nutrition 0.000 description 1
- 239000011677 pyridoxine Substances 0.000 description 1
- 230000000306 recurrent effect Effects 0.000 description 1
- 239000007921 spray Substances 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 231100000397 ulcer Toxicity 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229940011671 vitamin b6 Drugs 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/46—Hydrolases (3)
- A61K38/465—Hydrolases (3) acting on ester bonds (3.1), e.g. lipases, ribonucleases
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- Gastroenterology & Hepatology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Cosmetics (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BE623473A true BE623473A (de) |
Family
ID=195605
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BE623473D BE623473A (de) |
Country Status (1)
| Country | Link |
|---|---|
| BE (1) | BE623473A (de) |
-
0
- BE BE623473D patent/BE623473A/fr unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP4903131B2 (ja) | 先天性免疫修飾疾患を処置および予防するためのｄ−マンノヘプツロースおよび／またはペルセイトールを含んでなる化合物の使用 | |
| EP2134316B1 (de) | Neuartige kosmetische und/oder pharmazeutische zusammensetzungen und deren verwendungen | |
| EP2155222B1 (de) | Extrakt von trigonella foenum graecum | |
| FR2650504A1 (fr) | Hydrochlorure monohydrate de l'ester ethylique de l'acide 6-bromo-5-hydroxy-4-dimethylaminomethyl-1-methyl-2-phenylthiomethylindole-3-carbonique, procede pour son obtention et medicament antiviral comprenant ce produit | |
| JP6400851B2 (ja) | ニキビ除去のための医薬組成物とその製造方法 | |
| Ahuja et al. | Apitherapy–A sweet approach to dental diseases-Part I: Honey | |
| WO2019101867A1 (fr) | Composition à base de quercétine pour le traitement de la rhinosinusite | |
| WO2000074668A1 (fr) | Composition non solide pour application locale | |
| Karic et al. | Effectiveness of Allium sativum on bacterial oral infection | |
| EP2288357A1 (de) | Zusammensetzungen mit polysacchariden von roten mikroalgen und metallen | |
| US20170152285A1 (en) | Extracting method of kuguacin, pharmaceutical composition comprising the kuguacin and use thereof | |
| TWI716073B (zh) | 具抗氧化與延緩衰老功效之菇類萃取物的用途 | |
| FR2843883A1 (fr) | Extraits de sangsues pour psoriasis | |
| CN102068482B (zh) | 紫景天总黄酮及其提取方法和药物用途 | |
| FR2931664A1 (fr) | Compositions a base de plantes et utilisations | |
| FR2855056A1 (fr) | Medicament notamment pour le traitement de la drepanocytose ou du sida | |
| CN106729672A (zh) | 一种治疗上呼吸道黏膜炎的组合物及其应用 | |
| WO2023046892A1 (fr) | Solution aqueuse a base de syzygium aromaticum, procede de preparation et utilisations associees | |
| RU2623061C1 (ru) | Средство для лечения заболеваний кожи, обладающее противовоспалительным, ранозаживляющим, антибактериальным, противовирусным, противогрибковым действием | |
| EP2694081A1 (de) | Tnf-alpha-inhibitor | |
| BE888843A (fr) | Procede de preparation d'un agent antimicrobien, composition antimicrobienne, medicament comprenant cette composition | |
| Ahuja et al. | Apitherapy and Dentistry | |
| WO2005018655A1 (fr) | Utilisation du noni lors de pathologies bucco dentaires notamment pour combattre les problemes d’asialie et d’hyposialie | |
| FR2855055A1 (fr) | Medicament notamment pour le traitement de la depranocytose ou du sida | |
| EP0233459A1 (de) | Magnesium-Harnstoff-Komplex der Acetylsalicylsäure enthaltendes Heilmittel und Verfahren zur Herstellung dieses Komplexes |